Cite Filings / AXSM / 0000950170-25-072022

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Axsome Therapeutics, Inc. Filed 2025-05-15 Acc 0000950170-25-072022

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-20 144 Sale of Securities
2025-05-20 4 Director sold 3,000 shares at $107.49 ($322,473)
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-05-13 8-K Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Other events
2025-02-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…